Results 251 to 260 of about 52,263 (284)

Fractionated stereotactic radiotherapy for craniopharyngiomas

International Journal of Radiation Oncology*Biology*Physics, 2002
To investigate outcome and toxicity after fractionated stereotactic radiation therapy (FSRT) in patients with craniopharyngiomas.Twenty-six patients with craniopharyngiomas were treated with FSRT between May 1989 and February 2001. Median age was 33.5 years (range: 5-57 years).
Daniela, Schulz-Ertner, Claudia, Frank, Klaus K, Herfarth, Bernhard, Rhein, Michael, Wannenmacher, Jürgen, Debus   +5 more
openaire   +2 more sources

Stereotactic radiotherapy and oligometastases

The Lancet Oncology, 2021
Fergus, Macbeth, Raymond, Abratt
openaire   +2 more sources

Stereotactic Radiotherapy for Vestibular Schwannoma

Otolaryngologic Clinics of North America, 2009
Vestibular schwannomas are benign tumors of the Schwann cells of the eighth (VIII) cranial nerve. Precision radiotherapy techniques used to manage these tumors include stereotactic radiotherapy (SRT), which can be delivered with either a conventional or hypofractionated regimen.
Patrick, Sweeney, Santosh, Yajnik, William, Hartsell, George, Bovis, Jagannath, Venkatesan   +4 more
openaire   +2 more sources

Stereotactic radiotherapy of spinal hemangioblastoma

Burdenko's Journal of Neurosurgery
Hemangioblastoma (HAB) is a benign, richly vascularized tumor that accounts for 2—6% of all spinal cord neoplasms and ranks third in the structure of intramedullary space-occupying lesions of the spinal cord. Hemangioblastoma may occur sporadically or, in approximately 30% of cases, as part of the clinical picture of a hereditary disease, von Hippel ...
A.I. Lestrovaya, A.V. Golanov, N.A. Konovalov, I.N. Pronin, I.I. Danilina, Yu.V. Strunina   +5 more
openaire   +2 more sources

Stereotactic radiotherapy for prostate cancer

Cancer/Radiothérapie
Stereotactic body radiotherapy, also referred to as extreme hypofractionation, uses advanced delivery techniques to administer high radiation doses per fraction. Since its introduction in the early 2000s, several single-centre and two multi-institutional randomized trials have evaluated stereotactic body radiotherapy for prostate cancer, typically ...
Ulrike, Schick, Delphine, Antoni, Stéphanie, Josset, Thomas, Lacornerie, Jocelyne, Mazurier, Laure, Parent, David, Pasquier   +6 more
openaire   +2 more sources

Stereotactic synchrotron microbeam radiotherapy

Australasian Physics & Engineering Sciences in Medicine, 2002
Highly collimated synchrotron x-ray beams with high fluence rate may be used in stereotactic radiotherapy of brain tumours. Several monochromatic x-ray beams having uniform microscopic thickness ie (microplanar beams) are directed to the center of the tumour from varying directions, delivering lethal dose to the target volume while sparing normal cells.
openaire   +2 more sources

Lessons in stereotactic radiotherapy for oligometastases

Journal of Medical Imaging and Radiation Sciences, 2022
Alexander V, Louie, Arjun, Sahgal
openaire   +2 more sources

Stereotactic Radiotherapy for Lung Tumors

2014
Early stage lung cancer may often be not amenable for surgery due to poor underlying lung function. While conventional radiation therapy may be utilized, respiratory motion often implies inclusion of large volumes of normal lung, to cover the planning target volume with the attending morbidity.
openaire   +2 more sources

Stereotactic Body Radiotherapy/Stereotactic Ablative Body Radiotherapy for Lung Cancer

2013
Technological advances in radiation oncology have led to clinical implementation of novel treatment modality. Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) is an emerging treatment paradigm as a result of image-guidance technology and more sophisticated computational treatment planning system.
Hua Ren, Shanda Blackmon, Bin S. Teh
openaire   +1 more source

Stereotactic Radiotherapy

1998
William A. Friedman, Francis J. Bova, John M. Buatti, William M. Mendenhall   +3 more
openaire   +1 more source